DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
China flag China · Delayed Price · Currency is CNY
20.74
-0.08 (-0.38%)
Nov 18, 2026, 2:55 PM CST

SHA:603233 Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, SHA:603233 stock has a consensus rating of "Buy" and an average price target of ¥24.03. The average 1-year stock price forecast is 15.86% higher than the current stock price, while the lowest is ¥15.00 (-27.68%) and the highest is ¥26.80 (+29.22%).

Price Target: ¥24.03 (+15.86%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price¥15.00¥24.03¥25.00¥26.80
Change-27.68%+15.86%+20.54%+29.22%

Analyst Ratings

The average analyst rating for SHA:603233 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy666666
Buy445555
Hold000000
Sell000000
Strong Sell000111
Total101011121212

Financial Forecast

Revenue This Year
29.57B
from 27.50B
Increased by 7.51%
Revenue Next Year
32.52B
from 29.57B
Increased by 9.98%
EPS This Year
1.30
from 1.07
Increased by 21.55%
EPS Next Year
1.52
from 1.30
Increased by 17.13%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
16.76B21.25B24.53B26.50B27.50B29.57B
Revenue Growth
14.93%26.78%15.45%8.01%3.80%7.51%
Gross Profit
6.37B8.02B8.74B9.07B9.41B10.12B
Gross Margin
38.03%37.76%35.61%34.25%34.22%34.23%
Operating Income
1.10B1.59B1.80B1.55B2.04B2.41B
Net Income
791.23M1.04B1.17B914.75M1.24B1.51B
EPS
----1.071.30
EPS Growth
----36.77%21.55%
Forward PE
28.0631.3723.7616.4416.9715.99
Dividend / Share
0.350.500.310.620.830.95
Dividend Growth
-24.99%43.97%-38.00%100.00%33.87%14.24%
Free Cash Flow
----4.89B1.72B
No. Analysts
-----6
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High29.7B
Avg29.6B
Low29.4B

Revenue Growth

Revenue Growth202620272028
High
8.1%
Avg
7.5%
Low
6.7%

EPS Forecast

EPS202620272028
High1.33
Avg1.30
Low1.24

EPS Growth

EPS Growth202620272028
High
24.7%
Avg
21.5%
Low
16.2%